Administration of injectable cosmetic treatments
April 10, 2009 by admin
The NMC has updated its advice (January 2009) on the administration of injectable cosmetic treatments. It says that the administration of, for example, a botulinum toxin injection, by a patient group direction or patient specific direction that has been signed remotely by someone who has not seen the patient is contrary to its ‘Standards for Medicines Management’ Any injectable cosmetic treatment should only be administered after a registered prescriber has made a comprehensive assessment and written and signed the prescription. Remote prescribing should not be used routinely to administer such injections.
NB: The NMC has now removed this advice sheet from its website because it says some of the information was “potentially misleading” and it will be updated as soon as possible.
Comments
Categories
Recent Posts
- Non-medical prescribing in A and E and sexual health
- Formularies can support prescribing in mental health
- GP prescribing errors study hit headlines
- RCN briefing on nurse prescribing
- CDs: prescribing, mixing and PGDs - more information now available
- 23 April: CD changes come into effect
- ANP 2012 conference dates announced
- NICE to produce medicines adherence standard
- Consultation on healthcare regulators
- Home Office says CD changes expected in April
Tags
- ANP ANP conference Carey N CD children CKS Clinical Knowledge Summaries consultation controlled drugs COPD cosmetic treatments Courtenay Courtenay M CPD dermatology DH diabetes district nurse prescriber generic substitution Home Office Matt Griffiths mental health MeReC MHRA Misuse of Drugs Misuse of Drugs Act mixing medicines National Prescribing Centre NICE NMC non-medical prescribing NPC NPF NPSA Nurse prescribing Patient Group Directions PGD PGDs Prescribing Prescribing errors RCN Stenner Stenner K supplementary prescribers unlicensed medicines
